| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Abbas Mirshafiey | |
| Farhad Jadidi-Niaragh | |||
| P2860 | cites work | The Pathology of MS | Q22242764 |
| TCR beta polymorphisms and multiple sclerosis | Q47399912 | ||
| Protective role of the HLA-A*02 allele in Portuguese patients with multiple sclerosis. | Q47687523 | ||
| Quantitative estimation of the albumin and gamma globulin in normal and pathologic cerebrospinal fluid by immunochemical methods | Q47857522 | ||
| NKT cells: what's in a name? | Q47895830 | ||
| Oral administration of myelin induces antigen-specific TGF-beta 1 secreting T cells in patients with multiple sclerosis | Q48003302 | ||
| HLA-G expression defines a novel regulatory T-cell subset present in human peripheral blood and sites of inflammation. | Q48235309 | ||
| Increased frequency of CD4+ CD25+ regulatory T cells in the cerebrospinal fluid but not in the blood of multiple sclerosis patients. | Q48271985 | ||
| Polyclonal expansion of regulatory T cells interferes with effector cell migration in a model of multiple sclerosis. | Q48442373 | ||
| Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination | Q48489118 | ||
| Differentiation of regulatory T cells 1 is induced by CD2 costimulation | Q24291651 | ||
| Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype | Q24293121 | ||
| Expression of the integrin alpha Ebeta 7 identifies unique subsets of CD25+ as well as CD25- regulatory T cells | Q24538658 | ||
| The T-cell pool is anergized in patients with multiple sclerosis in remission | Q24643433 | ||
| Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25– T cells | Q24645614 | ||
| Redundancy in antigen-presenting function of the HLA-DR and -DQ molecules in the multiple sclerosis-associated HLA-DR2 haplotype | Q24652223 | ||
| T-cell regulation by CD46 and its relevance in multiple sclerosis | Q24653362 | ||
| Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3 | Q24672849 | ||
| Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation | Q24676080 | ||
| Control of regulatory T cell development by the transcription factor Foxp3 | Q27860489 | ||
| Foxp3 programs the development and function of CD4+CD25+ regulatory T cells | Q27860714 | ||
| Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4 | Q28204758 | ||
| The B7 family revisited | Q28240070 | ||
| Central role of ILT3 in the T suppressor cell cascade | Q28252559 | ||
| The inhibitory cytokine IL-35 contributes to regulatory T-cell function | Q28258462 | ||
| CD24 gene polymorphism is associated with the disease progression and susceptibility to multiple sclerosis in the Iranian population | Q28263961 | ||
| Regulation of immune responses by TGF-beta | Q28271433 | ||
| The biology of NKT cells | Q28277482 | ||
| IL-21 is produced by NKT cells and modulates NKT cell activation and cytokine production | Q28289204 | ||
| NKT cells derive from double-positive thymocytes that are positively selected by CD1d | Q28508188 | ||
| MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis | Q28509195 | ||
| T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation | Q28511506 | ||
| The ETS protein MEF plays a critical role in perforin gene expression and the development of natural killer and NK-T cells | Q28512367 | ||
| A function for interleukin 2 in Foxp3-expressing regulatory T cells | Q28590646 | ||
| GATA-3 regulates the development and function of invariant NKT cells | Q28590905 | ||
| FOXP3+ regulatory T cells in the human immune system | Q29307487 | ||
| Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain | Q29614225 | ||
| How regulatory T cells work | Q29614262 | ||
| IDO expression by dendritic cells: tolerance and tryptophan catabolism | Q29614752 | ||
| Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination | Q29614990 | ||
| Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression | Q29615344 | ||
| Multiple sclerosis | Q29616022 | ||
| CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells | Q29618394 | ||
| Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self | Q29619194 | ||
| A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis | Q29619339 | ||
| Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE. | Q33240824 | ||
| Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections | Q50092191 | ||
| Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function. | Q51032192 | ||
| Peptide specificity of thymic selection of CD4+CD25+ T cells. | Q51058071 | ||
| Cutting edge: CD4+CD25+ regulatory T cells contribute to gender differences in susceptibility to experimental autoimmune encephalomyelitis. | Q51835987 | ||
| Interferon beta-induced restoration of regulatory T-cell function in multiple sclerosis is prompted by an increase in newly generated naive regulatory T cells. | Q51960750 | ||
| Natural naive CD4+CD25+CD127low regulatory T cell (Treg) development and function are disturbed in multiple sclerosis patients: recovery of memory Treg homeostasis during disease progression. | Q51965369 | ||
| Prevalence of newly generated naive regulatory T cells (Treg) is critical for Treg suppressive function and determines Treg dysfunction in multiple sclerosis. | Q51973817 | ||
| Sensitivity of NK1.1-negative NKT cells to transgenic BATF defines a role for activator protein-1 in the expansion and maturation of immature NKT cells in the thymus. | Q51998750 | ||
| Regulatory CD8+CD28- T cells in heart transplant recipients. | Q52008620 | ||
| NK1.1+ T cells from IL-7-deficient mice have a normal distribution and selection but exhibit impaired cytokine production. | Q52891433 | ||
| CD25 regulatory T cells determine secondary but not primary remission in EAE: impact on long-term disease progression. | Q52935577 | ||
| A biased Valpha24+ T-cell repertoire leads to circulating NKT-cell defects in a multiple sclerosis patient at the onset of his disease. | Q52958014 | ||
| Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity. | Q53271841 | ||
| Rapamycin enriches for CD4(+) CD25(+) CD27(+) Foxp3(+) regulatory T cells in ex vivo-expanded CD25-enriched products from healthy donors and patients with multiple sclerosis. | Q53557761 | ||
| Paralysis of CD4(+)CD25(+) regulatory T cell response in chronic autoimmune encephalomyelitis. | Q53570832 | ||
| B7H1-Ig fusion protein activates the CD4+ IFN-gamma receptor+ type 1 T regulatory subset through IFN-gamma-secreting Th1 cells. | Q53601507 | ||
| Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis. | Q53654834 | ||
| Peptide-specific CD8 T regulatory cells use IFN-gamma to elaborate TGF-beta-based suppression. | Q53671871 | ||
| Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+CD25+ regulatory cells within the central nervous system. | Q53846430 | ||
| IL-2, IFN-gamma, and IL-12 gene polymorphisms and susceptibility to multiple sclerosis. | Q54476654 | ||
| How many mechanisms do regulatory T cells need? | Q54568607 | ||
| An inverse correlation of human peripheral blood regulatory T cell frequency with the disease activity of ulcerative colitis. | Q54608720 | ||
| Autoreactive human peripheral blood CD8+ T cells with a regulatory phenotype and function. | Q54641462 | ||
| Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans. | Q54645452 | ||
| Osteopontin as a mediator of NKT cell function in T cell-mediated liver diseases. | Q54697381 | ||
| Human CD8+CD25+ thymocytes share phenotypic and functional features with CD4+CD25+ regulatory thymocytes | Q56903667 | ||
| EVI5 is a risk gene for multiple sclerosis | Q57309121 | ||
| Susceptibility to multiple sclerosis and the immunoglobulin heavy chain variable region | Q58133075 | ||
| Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells | Q58234949 | ||
| Interleukin-10 and tumor necrosis factor-alpha: model of immunomodulation in multiple sclerosis | Q58832274 | ||
| Early events in the thymus affect the balance of effector and regulatory T cells | Q59077338 | ||
| Foxp3-dependent programme of regulatory T-cell differentiation | Q59084714 | ||
| Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+regulatory T-cell function and FOXP3 expression | Q59149671 | ||
| Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells | Q36370232 | ||
| In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. | Q36370315 | ||
| Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining | Q36370359 | ||
| Antigen-dependent proliferation of CD4+ CD25+ regulatory T cells in vivo | Q36371283 | ||
| Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells | Q36371345 | ||
| Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand alpha-Galactosylceramide | Q36371546 | ||
| The Src family tyrosine kinase Fyn regulates natural killer T cell development | Q36375458 | ||
| Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease | Q36380402 | ||
| Tr1 cells: from discovery to their clinical application. | Q36390028 | ||
| The transcription factor interferon regulatory factor 1 (IRF-1) is important during the maturation of natural killer 1.1+ T cell receptor-alpha/beta+ (NK1+ T) cells, natural killer cells, and intestinal intraepithelial T cells | Q36400520 | ||
| Regulatory CD4(+) T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis | Q36401257 | ||
| Essential role for interleukin-2 for CD4(+)CD25(+) T regulatory cell development during the neonatal period | Q36402733 | ||
| Developmental regulation of Foxp3 expression during ontogeny. | Q36403564 | ||
| In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers | Q36404648 | ||
| Multiple sclerosis--the plaque and its pathogenesis | Q36410882 | ||
| Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. | Q36457107 | ||
| CD4+CD25+ Tregs and NKT cells: regulators regulating regulators | Q36492658 | ||
| Th17: an effector CD4 T cell lineage with regulatory T cell ties | Q36510274 | ||
| Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease | Q36672085 | ||
| An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locus | Q36693352 | ||
| T(H)-17 cells in the circle of immunity and autoimmunity | Q36765453 | ||
| NKT cells: T lymphocytes with innate effector functions | Q36788766 | ||
| Control points in NKT-cell development | Q36858868 | ||
| Multiple sclerosis: a complicated picture of autoimmunity. | Q36915907 | ||
| Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populations | Q36930892 | ||
| Understanding the behavior of invariant NKT cells in autoimmune diseases | Q36955593 | ||
| Regulatory T cells and infection: a dangerous necessity | Q36975739 | ||
| Foxp3+ regulatory T cells in the control of experimental CNS autoimmune disease | Q37031066 | ||
| NKT cell-dependent amelioration of a mouse model of multiple sclerosis by altering gut flora | Q37061082 | ||
| Mechanisms of regulatory T-cell suppression - a diverse arsenal for a moving target | Q37111968 | ||
| Is FOXP3 a bona fide marker for human regulatory T cells? | Q37131913 | ||
| The suppression of hypersensitivity by ocular-induced CD8(+) T cells requires compatibility in the Qa-1 haplotype | Q37135668 | ||
| Emerging concepts in CD8(+) T regulatory cells | Q37136267 | ||
| Invariant NKT cells inhibit development of the Th17 lineage | Q37159061 | ||
| Cytotoxic T lymphocyte antigen-4-dependent down-modulation of costimulatory molecules on dendritic cells in CD4+ CD25+ regulatory T-cell-mediated suppression | Q33246674 | ||
| Association between protective and deleterious HLA alleles with multiple sclerosis in Central East Sardinia | Q33490625 | ||
| TGF-beta and regulatory T cell in immunity and autoimmunity | Q33722462 | ||
| Immune regulatory CNS-reactive CD8+T cells in experimental autoimmune encephalomyelitis | Q33886414 | ||
| Foxp3+ CD25- CD4 T cells constitute a reservoir of committed regulatory cells that regain CD25 expression upon homeostatic expansion | Q33932451 | ||
| Specificity requirements for selection and effector functions of CD25+4+ regulatory T cells in anti-myelin basic protein T cell receptor transgenic mice. | Q34032006 | ||
| NKT cells: facts, functions and fallacies. | Q34091324 | ||
| Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance | Q34111451 | ||
| CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor | Q34116317 | ||
| Histamine and histamine receptors in pathogenesis and treatment of multiple sclerosis | Q34116965 | ||
| Sea-level fingerprinting as a direct test for the source of global meltwater pulse IA. | Q34118671 | ||
| Selective immunointervention in autoimmune diseases: lessons from multiple sclerosis | Q34307160 | ||
| Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis | Q34311395 | ||
| IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells | Q34318928 | ||
| Role of LAG-3 in regulatory T cells. | Q34358935 | ||
| Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism | Q34392100 | ||
| Control of T-cell activation by CD4+ CD25+ suppressor T cells | Q34448423 | ||
| Type 1 T regulatory cells. | Q34448429 | ||
| Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. | Q34509694 | ||
| Cytotoxic T lymphocyte antigen-4 accumulation in the immunological synapse is regulated by TCR signal strength | Q34520749 | ||
| Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells. | Q34529123 | ||
| Development and selection of NKT cells | Q34547258 | ||
| Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. | Q34569888 | ||
| CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer | Q34585720 | ||
| Cutting edge: NKT cells constitutively express IL-23 receptor and RORgammat and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion | Q34590084 | ||
| Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. | Q34621389 | ||
| Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease | Q34693075 | ||
| CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells | Q34709777 | ||
| Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases. | Q34710256 | ||
| Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis | Q34719541 | ||
| NKT cells: potential targets for autoimmune disease therapy? | Q34764715 | ||
| Glatiramer acetate (Copaxone) therapy induces CD8(+) T cell responses in patients with multiple sclerosis | Q34789216 | ||
| B cells and multiple sclerosis | Q34808657 | ||
| Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis | Q35127765 | ||
| Foxp3 and natural regulatory T cells: key to a cell lineage? | Q35204514 | ||
| Association of the APOE epsilon4 allele with disease activity in multiple sclerosis | Q35452445 | ||
| The regulatory T cell family: distinct subsets and their interrelations | Q35603236 | ||
| Identification of a human CD8+ regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4. | Q35808883 | ||
| Activated CD4+CD25+ T cells selectively kill B lymphocytes | Q35848308 | ||
| T-bet concomitantly controls migration, survival, and effector functions during the development of Valpha14i NKT cells | Q35848548 | ||
| Regulatory T cells: friend or foe in immunity to infection? | Q35934156 | ||
| Regulatory functions of CD8+CD28– T cells in an autoimmune disease model | Q36001202 | ||
| Neuroprotection from complement-mediated inflammatory damage | Q36024930 | ||
| Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype | Q36059631 | ||
| Developmental program of mouse Valpha14i NKT cells | Q36070685 | ||
| Toward an understanding of NKT cell biology: progress and paradoxes | Q36072480 | ||
| Signaling for NKT cell development: the SAP-FynT connection | Q36076597 | ||
| The B7/CD28 costimulatory family in autoimmunity | Q36079881 | ||
| Immunotherapeutic potential for ceramide-based activators of iNKT cells | Q36110182 | ||
| Regulation of immunity by self-reactive T cells | Q36148406 | ||
| Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. | Q36189566 | ||
| IL-23 produced by CNS-resident cells controls T cell encephalitogenicity during the effector phase of experimental autoimmune encephalomyelitis. | Q36259695 | ||
| The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage | Q36299396 | ||
| Major histocompatibility complex class I related molecules control the development of CD4+8- and CD4-8- subsets of natural killer 1.1+ T cell receptor-alpha/beta+ cells in the liver of mice | Q36363483 | ||
| Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions | Q36365596 | ||
| Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction | Q36368672 | ||
| Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. | Q36369797 | ||
| Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis | Q36369830 | ||
| A natural killer T (NKT) cell developmental pathway iInvolving a thymus-dependent NK1.1(-)CD4(+) CD1d-dependent precursor stage | Q36370202 | ||
| Suppressor T cells in human diseases | Q42971257 | ||
| Functionally distinct NKT cell subsets and subtypes | Q42972264 | ||
| The CTLA-4 gene polymorphisms are associated with CTLA-4 protein expression levels in multiple sclerosis patients and with susceptibility to disease | Q43279096 | ||
| Glucocorticoid treatment restores the impaired suppressive function of regulatory T cells in patients with relapsing-remitting multiple sclerosis | Q43279655 | ||
| A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells | Q43756252 | ||
| Expansion of regulatory CD8+ T-lymphocytes and fall of activated CD8+ T-lymphocytes after i.v. methyl-prednisolone for multiple sclerosis relapse. | Q43925131 | ||
| CD4+CD25+FoxP3+PD1- regulatory T cells in acute and stable relapsing-remitting multiple sclerosis and their modulation by therapy. | Q43945959 | ||
| NK T cell precursors exhibit differential cytokine regulation and require Itk for efficient maturation | Q44113021 | ||
| Recognition of bacterial glycosphingolipids by natural killer T cells | Q44582192 | ||
| Modulation of tryptophan catabolism by regulatory T cells. | Q44632333 | ||
| Effect of glatiramer acetate (Copaxone) on CD4+CD25high T regulatory cells and their IL-10 production in multiple sclerosis | Q44641644 | ||
| Identification of a novel natural regulatory CD8 T-cell subset and analysis of its mechanism of regulation. | Q44991530 | ||
| Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. | Q45299244 | ||
| A unifying multiple sclerosis etiology linking virus infection, sunlight, and vitamin D, through viral interleukin-10. | Q45396039 | ||
| Growth and expansion of human T regulatory type 1 cells are independent from TCR activation but require exogenous cytokines | Q45889051 | ||
| Glatiramer acetate improves regulatory T-cell function by expansion of naive CD4(+)CD25(+)FOXP3(+)CD31(+) T-cells in patients with multiple sclerosis. | Q45914495 | ||
| Dysregulation of IL-10 and IL-12p40 in secondary progressive multiple sclerosis | Q46065971 | ||
| Osteopontin-induced relapse and progression of autoimmune brain disease through enhanced survival of activated T cells. | Q46078718 | ||
| HIV-specific IL-10-positive CD8+ T cells suppress cytolysis and IL-2 production by CD8+ T cells | Q46342730 | ||
| The SH2D2A gene and susceptibility to multiple sclerosis | Q46539653 | ||
| Generation of highly suppressive adaptive CD8(+)CD25(+)FOXP3(+) regulatory T cells by continuous antigen stimulation | Q46760280 | ||
| CD7 and CD28 are required for murine CD4+CD25+ regulatory T cell homeostasis and prevention of thyroiditis | Q47283198 | ||
| Astrocyte-induced regulatory T cells mitigate CNS autoimmunity. | Q47374946 | ||
| Immune regulation by invariant NKT cells in autoimmunity | Q37175394 | ||
| Revival of CD8+ Treg-mediated suppression | Q37178215 | ||
| The genetics of multiple sclerosis: SNPs to pathways to pathogenesis | Q37187340 | ||
| The role of regulatory T cells in multiple sclerosis | Q37199648 | ||
| Gender and sex hormones in multiple sclerosis pathology and therapy. | Q37209917 | ||
| Multiple sclerosis and regulatory T cells | Q37258383 | ||
| Antioxidant therapy in multiple sclerosis. | Q37258404 | ||
| The development and function of regulatory T cells | Q37274250 | ||
| CD8+ regulatory T cells-A distinct T-cell lineage or a transient T-cell phenotype? | Q37279450 | ||
| Kinetics and cellular site of glycolipid loading control the outcome of natural killer T cell activation | Q37285947 | ||
| Human CD4 and CD8 regulatory T cells in infectious diseases and vaccination | Q37286650 | ||
| Novel therapeutic strategies for multiple sclerosis--a multifaceted adversary | Q37313911 | ||
| Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients | Q37356987 | ||
| Latency-associated peptide identifies a novel CD4+CD25+ regulatory T cell subset with TGFbeta-mediated function and enhanced suppression of experimental autoimmune encephalomyelitis | Q37408819 | ||
| TGF-beta as a promising option in the treatment of multiple sclerosis. | Q37414480 | ||
| Regulatory and pro-inflammatory phenotypes of myelin basic protein-autoreactive T cells in multiple sclerosis | Q37426985 | ||
| Development of Valpha4+ NK T cells in the early stages of embryogenesis | Q37527374 | ||
| Myelin proteolipid protein-specific CD4+CD25+ regulatory cells mediate genetic resistance to experimental autoimmune encephalomyelitis | Q37593413 | ||
| Regulatory T cells and inhibitory cytokines in autoimmunity | Q37621070 | ||
| Recent advances in processing and presentation of CD1 bound lipid antigens | Q37676539 | ||
| Immunopharmacological role of the leukotriene receptor antagonists and inhibitors of leukotrienes generating enzymes in multiple sclerosis. | Q37713745 | ||
| Invariant NKT cells regulate experimental autoimmune encephalomyelitis and infiltrate the central nervous system in a CD1d-independent manner | Q38476162 | ||
| Immunoglobulin-containing cells in multiple-sclerosis plaques | Q39450637 | ||
| Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis | Q39808633 | ||
| Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance | Q40071336 | ||
| Control of immune responses by antigen-specific regulatory T cells expressing the folate receptor. | Q40110921 | ||
| Novel immunosuppressive therapy by M2000 in experimental multiple sclerosis | Q40382676 | ||
| Decreased FOXP3 levels in multiple sclerosis patients | Q40414528 | ||
| Large-scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells. | Q40565739 | ||
| Oligoclonal expansion of memory CD8+ T cells in cerebrospinal fluid from multiple sclerosis patients | Q40656580 | ||
| IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells. | Q40811244 | ||
| Regulation of experimental autoimmune encephalomyelitis in the C57BL/6J mouse by NK1.1+, DX5+, alpha beta+ T cells | Q40822117 | ||
| Chemokine receptor expression and function in CD4+ T lymphocytes with regulatory activity. | Q40833931 | ||
| A rare variant of the TYK2 gene is confirmed to be associated with multiple sclerosis | Q41738233 | ||
| Human CD4(+)CD25(+) regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells [corrected]. | Q41907086 | ||
| Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells | Q41908906 | ||
| Importance of intrathecal synthesis of IgD in multiple sclerosis. A combined clinical, immunologic, and magnetic resonance imaging study | Q41982746 | ||
| TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs | Q42181372 | ||
| MicroRNA--managing the TH-17 inflammatory response | Q42732940 | ||
| Cytotoxicity of fresh NK1.1+ T cell receptor alpha/beta+ thymocytes against a CD4+8+ thymocyte population associated with intact Fas antigen expression on the target | Q42942508 | ||
| Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells | Q42944333 | ||
| Abnormal Tr1 differentiation in multiple sclerosis | Q42953557 | ||
| Multiple tissue-specific isoforms of sulfatide activate CD1d-restricted type II NKT cells | Q42966143 | ||
| P433 | issue | 3 | |
| P921 | main subject | multiple sclerosis | Q8277 |
| immunosuppression | Q1455316 | ||
| P304 | page(s) | 545-567 | |
| P577 | publication date | 2011-02-02 | |
| P1433 | published in | Immunopharmacology and Immunotoxicology | Q4200316 |
| P1476 | title | Regulatory T-cell as orchestra leader in immunosuppression process of multiple sclerosis | |
| P478 | volume | 33 |
| Q38896543 | Application of nanomedicine for crossing the blood-brain barrier: Theranostic opportunities in multiple sclerosis. |
| Q37316205 | BCG and BCG/DNAhsp65 vaccinations promote protective effects without deleterious consequences for experimental autoimmune encephalomyelitis |
| Q89820664 | Event-Driven Immunoprofiling Predicts Return of Disease Activity in Alemtuzumab-Treated Multiple Sclerosis |
| Q38617794 | IL-21 and IL-21 receptor in the immunopathogenesis of multiple sclerosis. |
| Q38897883 | Identification, Isolation, and Functional Assay of Regulatory T Cells |
| Q38008077 | Immunology mini-review: the basics of T(H)17 and interleukin-6 in transplantation |
| Q36492808 | Inhibition of phosphoinositide 3-kinase delta attenuates experimental autoimmune encephalomyelitis in mice |
| Q28086853 | Multiple Sclerosis and T Lymphocytes: An Entangled Story |
| Q46816215 | Mycophenolate mofetil improves neurological function and alters blood T-lymphocyte subsets in rats with experimental autoimmune encephalomyelitis |
| Q37010063 | Persistent inflammation in the CNS during chronic EAE despite local absence of IL-17 production |
| Q38438986 | Rebamipide suppresses collagen-induced arthritis through reciprocal regulation of th17/treg cell differentiation and heme oxygenase 1 induction |
| Q26995751 | Regulatory T cell in stroke: a new paradigm for immune regulation |
| Q38107449 | Regulatory T cells in chronic lymphocytic leukemia: implication for immunotherapeutic interventions |
| Q41641061 | Selective depletion of CD11c+ CD11b+ dendritic cells partially abrogates tolerogenic effects of intravenous MOG in murine EAE. |
| Q64071344 | Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation |
| Q34589502 | Targeting the shift from M1 to M2 macrophages in experimental autoimmune encephalomyelitis mice treated with fasudil |
| Q37982395 | The deviated balance between regulatory T cell and Th17 in autoimmunity |
| Q38767477 | The role of adenosine and adenosine receptors in the immunopathogenesis of multiple sclerosis. |
| Q41582338 | The role of different subsets of regulatory T cells in immunopathogenesis of rheumatoid arthritis |
| Q38473746 | The skewed balance between Tregs and Th17 in chronic lymphocytic leukemia. |
| Q37683473 | pVAXhsp65 Vaccination Primes for High IL-10 Production and Decreases Experimental Encephalomyelitis Severity. |
Search more.